News Website

A Cross-Sectional Study of Endometriosis Surgeries Across Obstetrics and Gynecology Subspecialties: Does Minimally Invasive Gynecologic Surgery (MIGS) Fellowship Training Make a Difference?

Objective The objective of this study was to compare the surgical approaches and postoperative outcomes of endometriosis surgeries performed by different obstetrics and gynecology (OBGYN) subspecialties: minimally invasive gynecologic surgery …

Published: Aug. 23, 2025, midnight

Read Full Article

deep endometriosis deep endometriosis surgery deep infiltrative endometriosis endometriosis and chronic pelvic pain endometriosis excision laparoscopic surgery for endometriosis

Does This Patient Really Need a Gyn Oncology Referral? - Cleveland Clinic

Does This Patient Really Need a Gyn Oncology Referral? Cleveland Clinic

Published: Aug. 19, 2025, 4:55 a.m.

Read Full Article

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight - The Malaysian Reserve

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight The Malaysian Reserve

Published: Aug. 12, 2025, 10:20 p.m.

Read Full Article

AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in - GlobeNewswire

AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in GlobeNewswire

Published: Aug. 6, 2025, 1:03 p.m.

Read Full Article

First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

First immunotherapy combination for endometrial cancer approved by NICE Oncology Central

Published: Aug. 6, 2025, 11:18 a.m.

Read Full Article

Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer - Oncology Nursing News

Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer Oncology Nursing News

Published: June 27, 2025, 6:10 p.m.

Read Full Article

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - BioSpace

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting BioSpace

Published: May 23, 2025, 5:55 a.m.

Read Full Article

Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - The Manila Times

Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting The Manila Times

Published: May 23, 2025, 12:24 a.m.

Read Full Article

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting The Manila Times

Published: May 22, 2025, 9:19 p.m.

Read Full Article

Genmab to Highlight New Data Evaluating Late-Stage Oncology - GlobeNewswire

Genmab to Highlight New Data Evaluating Late-Stage Oncology GlobeNewswire

Published: May 22, 2025, 9:06 p.m.

Read Full Article

Latest Articles

A Cross-Sectional Study of Endometriosis Surgeries Across Obstetrics and Gynecology Subspecialties: Does Minimally Invasive Gynecologic Surgery (MIGS) Fellowship Training Make a Difference?

Does This Patient Really Need a Gyn Oncology Referral? - Cleveland Clinic

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight - The Malaysian Reserve

AIM ImmunoTech’s Oncology Drug Ampligen to Be Featured in - GlobeNewswire

First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

Selinexor Maintenance Offers Durable Benefit in Advanced Endometrial Cancer - Oncology Nursing News

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - BioSpace

Eisai to Present E7386, Co-created by PRISM BioLab and Eisai, at the ASCO (American Society of Clinical Oncology) Annual Meeting - The Manila Times

Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - The Manila Times

Genmab to Highlight New Data Evaluating Late-Stage Oncology - GlobeNewswire

Subscribe to Our Newsletter